Search

Your search keyword '"Rebecca Lyon"' showing total 21 results

Search Constraints

Start Over You searched for: Author "Rebecca Lyon" Remove constraint Author: "Rebecca Lyon" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
21 results on '"Rebecca Lyon"'

Search Results

1. Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial

2. A comparison of transporter gene expression in three species of Peronospora plant pathogens during host infection.

3. AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter

4. Population Structure of Peronospora effusa in the Southwestern United States.

5. Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

6. A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2

7. Pharmacokinetics of ß-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in non-plasma compartments of patients with SARS-CoV-2 infection

8. Pharmacokinetics of ss-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

9. An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2

10. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

11. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

12. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled study

13. Population Structure of Peronospora effusa in the Southwestern United States

14. Feasibility of promoting physical activity using mHEALTH technology in rural women: the step-2-it study

15. Genetic Mapping, Candidate Gene Identification and Marker Validation for Host Plant Resistance to the Race 4 of Fusarium oxysporum f. sp. cubense Using Musa acuminata ssp. malaccensis

16. 4-Nonylphenol in Sierra Nevada glaciers, California, USA

17. Identification of a Major QTL-Controlling Resistance to the Subtropical Race 4 of Fusarium oxysporum f. sp. cubense in Musa acuminata ssp. malaccensis

18. Food safety labelling of chicken to prevent campylobacteriosis: consumer expectations and current practices

19. Unique Secreted in Xylem Genes in Banana-Infecting Endophytic Fusarium Oxysporum

20. Fusarium oxysporum triggers tissue-specific transcriptional reprogramming in Arabidopsis thaliana.

21. Investigating the Association between Flowering Time and Defense in the Arabidopsis thaliana-Fusarium oxysporum Interaction.

Catalog

Books, media, physical & digital resources